MedPath

Caffeine Supplementation on Movement Patterns and Reactive Agility in Rugby Sevens Matches

Early Phase 1
Completed
Conditions
Exercise
Interventions
Dietary Supplement: Caffeine 6mg/kg
Dietary Supplement: Placebo
Registration Number
NCT06612463
Lead Sponsor
National Taiwan Sport University
Brief Summary

Caffeine is widely used by rugby players for its performance-enhancing effects. The main questions it aims to answer are: (1) the impact of caffeine supplementation on various performance metrics, including distance covered at different speeds, acceleration, deceleration, collisions, and repeated high-intensity efforts; and (2) reactive agility, across four matches over two consecutive days in collegiate male rugby sevens players.A position-matched, double-blind, randomized crossover design was employed, with six male collegiate rugby players (mean height: 1.78 ± 0.09 m, mean weight: 81.3 ± 9.2 kg) participating in two trials. Each trial consisted of a two-day tournament, with two matches per day. Movement was monitored using global positioning system units.

Detailed Description

This study employed a position-matched, double-blind, randomized crossover design. Pairs of participants with similar playing positions, specifically forwards or backs/scrum halves, were randomly assigned to either the caffeine or placebo trial. Each trial comprised a two-day rugby sevens tournament, with participants playing two matches per day. Following a 13-day washout period, participants switched to the alternate trial. Both the participants and the research personnel were blinded to the supplementation condition throughout the study period, with the assignment of supplements disclosed to research personnel only after all data analyses were completed.

Recruitment & Eligibility

Status
COMPLETED
Sex
Male
Target Recruitment
8
Inclusion Criteria
  • Have undergone regular rugby training for at least three years
  • Member of a Division I university rugby team
Exclusion Criteria
  • Musculoskeletal injury within one month prior to the study
  • Presence of major cardiovascular diseases
  • Presence of major metabolic diseases

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
CaffeineCaffeine 6mg/kgIn the caffeine trial, participants ingested a capsule containing 3 mg/kg caffeine (Wako Pure Chemical Industries, Ltd., Osaka, Japan) 60 min prior to the match.
PlaceboPlaceboIn the placebo trial, participants ingested a capsule containing starch (Chung-Yu Biotech Co LTD, Taichung, Taiwan) at the same time point.
Primary Outcome Measures
NameTimeMethod
Total Distance and Distance Covered in Speed ZonesEach trial contained 2 days, with 2 matches on each day. Each participant completed 2 trials

This variable was measured with wearable global positioning system device during rugby sevens matches. Speed is divided into six zones: standing and walking (0-6 km/h), jogging (6-12 km/h), cruising (12-14 km/h), striding (14-18 km/h), high-intensity running (18-20 km/h), and sprinting (\> 20 km/h). The distance covered in each speed zone and the total distance covered were recorded.

Acceleration and DecelerationEach trial contained 2 days, with 2 matches on each day. Each participant completed 2 trials

This variable was measured with wearable global positioning system device during rugby sevens matches. For an activity to be included in the analysis, the movement speed must exceed 5 km/h, and the acceleration must be greater than 2 m/s² or the deceleration must be less than -2 m/s², sustained for more than 0.9 s. If the interval between two movements is less than 1 s, the subsequent movement will be combined with the previous one for analysis. The frequency and distance covered during these acceleration and deceleration phases were recorded.

collisionEach trial contained 2 days, with 2 matches on each day. Each participant completed 2 trials

This variable was measured with wearable global positioning system device during rugby sevens matches. Collision is defined as the number of times a participant accumulates 0.5 s standing after body contact resulting in a fall. Specific collision events include rucks, tackles, and instances where a player falls after contact

Repeated High-Intensity EffortEach trial contained 2 days, with 2 matches on each day. Each participant completed 2 trials

This variable was measured with wearable global positioning system device during rugby sevens matches. A repeated high-intensity effort is defined as the completion of three or more high-intensity actions in succession, with rest periods of no more than 21 s between each action. The criteria for high-intensity actions include a movement speed of at least 14 km/h, an acceleration of at least 2 m/s², and a deceleration of at least -2 m/s²

Reactive AgilityEach trial contained 2 days, with 2 matches on each day. Reactive agility was measured before each match. Each participant completed 2 trials

The participants sprinted with the ball, passing through a light gate, after which an indicator light immediately displayed a left or right direction. The participants had to respond by changing direction according to the indicator and continue moving until they passed the second light gate positioned 1.5 m away from the indicator. The fastest time from two attempts was used for analysis.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

National Taiwan University of Sport

🇨🇳

Taichung, Taiwan

© Copyright 2025. All Rights Reserved by MedPath